|
1
|
Iyoda A, Hiroshima K, Nakatani Y and
Fujisawa T: Pulmonary large cell neuroendocrine carcinoma: Its
place in the spectrum of pulmonary carcinoma. Ann Thorac Surg.
84:702–707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bodey B, Bodey B Jr, Groger AM, Siegel SE
and Kaiser HE: Invasion and metastasis: The expression and
significance of matrix metalloproteinases in carcinomas of the
lung. In Vivo. 15:175–180. 2001.PubMed/NCBI
|
|
3
|
Makino T, Mikami T, Hata Y, Otsuka H,
Koezuka S, Isobe K, Tochigi N, Shibuya K, Homma S and Iyoda A:
Comprehensive biomarkers for personalized treatment in pulmonary
large cell neuroendocrine carcinoma: A comparative analysis with
adenocarcinoma. Ann Thorac Surg. 102:1694–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyoshi T, Umemura S, Matsumura Y, Mimaki
S, Tada S, Makinoshima H, Ishii G, Udagawa H, Matsumoto S, Yoh K,
et al: Genomic profiling of large-cell neuroendocrine carcinoma of
the lung. Clin Cancer Res. 23:757–765. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okumura S, Kohama K, Kim S, Iwao H, Miki N
and Taira E: Induction of gicerin/CD146 in the rat carotid artery
after balloon injury. Biochem Biophys Res Commun. 313:902–906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohsen-Kanson T, Hafner AL, Wdziekonski B,
Villageois P, Chignon-Sicard B and Dani C: Expression of cell
surface markers during self-renewal and differentiation of human
adipose-derived stem cells. Biochem Biophys Res Commun.
430:871–875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Z and Yan X: CD146, a
multi-functional molecule beyond adhesion. Cancer Lett.
330:150–162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng B, Ohuchida K, Chijiiwa Y, Zhao M,
Mizuuchi Y, Cui L, Horioka K, Ohtsuka T, Mizumoto K, Oda Y, et al:
CD146 attenuation in cancer-associated fibroblasts promotes
pancreatic cancer progression. Mol Carcinog. 55:1560–1572. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kristiansen G, Yu Y, Schluns K, Sers C,
Dietel M and Petersen I: Expression of the cell adhesion molecule
CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol.
25:77–81. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oka S, Uramoto H, Chikaishi Y and Tanaka
F: The expression of CD146 predicts a poor overall survival in
patients with adenocarcinoma of the lung. Anticancer Res.
32:861–864. 2012.PubMed/NCBI
|
|
11
|
Odate S, Nakamura K, Onishi H, Kojima M,
Uchiyama A, Nakano K, Kato M, Tanaka M and Katano M: TrkB/BDNF
signaling pathway is a potential therapeutic target for pulmonary
large cell neuroendocrine carcinoma. Lung Cancer. 79:205–214. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng B, Ohuchida K, Cui L, Zhao M, Shindo
K, Fujiwara K, Manabe T, Torata N, Moriyama T, Miyasaka Y, et al:
TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma
is involved in migration and invasion of cancer cells. Int J Oncol.
47:490–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y,
Feng J, Yang D, Fu L and Yan X: CD146, an epithelial-mesenchymal
transition inducer, is associated with triple-negative breast
cancer. Proc Natl Acad Sci USA. 109:1127–1132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lehmann JM, Riethmuller G and Johnson JP:
MUC18, a marker of tumor progression in human melanoma, shows
sequence similarity to the neural cell adhesion molecules of the
immunoglobulin superfamily. Proc Natl Acad Sci USA. 86:9891–9895.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imbert AM, Garulli C, Choquet E, Koubi M,
Aurrand-Lions M and Chabannon C: CD146 expression in human breast
cancer cell lines induces phenotypic and functional changes
observed in epithelial to mesenchymal transition. PLoS One.
7:e437522012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li G, Kalabis J, Xu X, Meier F, Oka M,
Bogenrieder T and Herlyn M: Reciprocal regulation of MelCAM and AKT
in human melanoma. Oncogene. 22:6891–6899. 2003. View Article : Google Scholar : PubMed/NCBI
|
